HelixNano key facts
- Operator of a native biotechnology company intended to enable previously impossible applications across human and non-human biology.
- It has raised $52.5M across 1 recorded rounds; the latest was Seed Round in Jan 2021.
- Notable investors include Y Combinator, Alumni Ventures, Pioneer Fund, Mana Ventures, Gaingels — 50 tracked in total.
- Status: Privately Held (backing).
Who backs HelixNano
50+Membership and data by Private Market View
- ·The complete investor list: 50 names
- ·Watch HelixNano: the Monday email on marks, rounds and moves
HelixNano funding rounds
1 roundsHow much has HelixNano raised?
HelixNano has raised $52.5 million in total; 1 of its rounds is on record. The most recent was a seed round in Jan 2021.
HelixNano investors
50 investors are on record for HelixNano, including Y Combinator, Alumni Ventures, Pioneer Fund and Mana Ventures. By type, the record holds 17 venture capital firms and 1 family office. The seed round in Jan 2021 drew 2 investors.
About HelixNano
Operator of a native biotechnology company intended to enable previously impossible applications across human and non-human biology. The company's platform uses artificial intelligence to leverage synthetic biology to safely and reliably express transgenes in humans for next-generation gene therapies, genome engineering, and beyond, allowing clinicians to treat patients suffering from various diseases.
- Industry
- Biotechnology
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2013
- Employees
- 27
- Website
- helixnano.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
HelixNano doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.